Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePutting the CAR-T Before the Horse: How Much Disclosure is Required Under Section 112(a) for Biotechnological Inventions?AuthorsLeBlanc, HayleySubjectsCHIMERIC antigen receptors; IMMUNE response; AMINO acid sequence; PATENT infringement; JUNO Therapeutics Inc.PublicationTulane Journal of Technology & Intellectual Property, 2022, Vol 24, p251ISSN1533-3531Publication typeArticle